FactSet Research Systems (FDS) Draws Fresh Valuation Focus, Is The Discount Warranted?

FactSet Research Systems Inc.

FactSet Research Systems Inc.

FDS

0.00

FactSet Research Systems (FDS) has drawn fresh attention after recent share price moves, with the stock closing at US$218.15 and recording mixed short and longer term returns that invite a closer look at its current valuation.

Set against a 12.5% 90 day share price gain, but a year to date share price decline of 23.4% and a 1 year total shareholder return decline of 49.3%, the latest pullback suggests momentum has been fading as investors reassess risk and valuation.

If you are comparing FactSet Research Systems with other financial data and analytics stocks or adjacent themes, it can help to broaden your watchlist and check out 20 top founder-led companies

With FactSet Research Systems still trading at a discount to some valuation estimates despite recent revenue and net income growth, the key question is whether today’s price reflects a mispricing or if the market is already accounting for potential future gains.

Most Popular Narrative: 30.5% Undervalued

At a last close of $218.15 versus a narrative fair value of $313.99, FactSet Research Systems is framed as materially undervalued, with the focus on how its business mix has shifted toward harder to disrupt infrastructure.

At the current price of ~210 USD, the market is valuing FactSet as a certain victim of generative AI ("SaaSPocalypse"), completely ignoring the company’s structural transformation over the last 5 years. FactSet no longer sells just access to stock prices (which can be commoditized); it sells operational infrastructure built on four strategic pillars that are extremely hard for a chatbot to replace: Cobalt (Private Markets), CUSIP (Global Standards), Vermilion (Reporting), and Portware (Execution).

Want to understand why this narrative sees FactSet Research Systems as more than a data terminal? The core thesis leans on margin rich platforms, expanding private markets exposure and a forward earnings multiple that assumes healthier profitability. Curious which revenue mix and profit assumptions sit underneath that $313.99 figure and how they link to that future P/E? The full narrative spells out those numbers and the logic tying them together.

Result: Fair Value of $313.99 (UNDERVALUED)

However, this FactSet Research Systems thesis still faces risks, including slower adoption of Cobalt or Vermilion by existing clients and tougher pricing pressure on core data products.

Next Steps

If this FactSet Research Systems narrative leaves you torn between concern and optimism, treat that tension as a prompt to act now. Inspect the numbers yourself, then weigh the 5 key rewards and 1 important warning sign.

Looking for more investment ideas beyond FactSet Research Systems?

If you only stop at FactSet Research Systems, you risk missing other stocks that could fit your style. Widen the net and let the numbers guide you.

  • Spot potential value opportunities early by scanning 44 high quality undervalued stocks, which pairs solid fundamentals with prices that may not fully reflect their financial profile.
  • Strengthen the quality of your watchlist by focusing on companies in the solid balance sheet and fundamentals stocks screener (48 results) that emphasize financial resilience and funding flexibility.
  • Round out your income ideas by checking the 7 dividend fortresses, which aims to combine higher yields with more durable payout records.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.